Mette Ilander^1*, Heinrich Schlums^2*, Ulla Olsson-Strömberg^3*, Hanna Lähteenmäki^1*, Tiina Kasanen^1*, Perttu Koskenvesa, MD^4*, Stina Söderlund^3*, Martin Höglund, Ass Prof^5*, Berit Markevärn^6*, Anders Själander^7*, Kourosh Lotfi^8*, Claes Malm^8*, Anna Lubking, MD^9*, Marja Ekblom^9*, Elena Holm^9*, Mats Björeman^10*, Sören Lehmann^11*, Leif Stenke, MD, PhD¹¹, Lotta Ohm^11*, Waleed Majeed, MD^12*, Martin C. Muller^13*, Hans Ehrencrona^14*, Henrik Hjorth-Hansen, MD, PhD¹⁵, Susanne Saussele¹³, Francois-Xavier Mahon, MD, PhD, Professor^16*, Kimmo Porkka, MD, PhD¹⁷, Joelle Guilhot, PhD¹⁸, Yenan Bryceson^2*, Johan Richter, MD, PhD^9* and Satu Mustjoki, MD, PhD⁴

¹Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Central Hospital Cancer Center, Helsinki, Finland
²Centre for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Stockholm, Sweden
³Department of Hematology, Uppsala University Hospital, Uppsala, Sweden
⁴Hematology Research Unit Helsinki, University of Helsinki and Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
⁵Hematology, Uppsala University Hospital, Uppsala, Sweden
⁶Dept of Hematology, Umeå University Hospital, Umeå, Sweden
⁷Department of Public Heath and Clinical Medicine, Umeå university, Umeå, Sweden
⁸Department of Hematology, Linköping University Hospital, Linköping, Sweden
⁹Department of Hematology and Vascular Disorders, Skåne University Hospital, Lund, Sweden
¹⁰University Hospital, Örebro, Sweden
¹¹Department of Medicine, Division of Hematology, Karolinska University Hospital, Stockholm, Sweden
¹²Stavanger University hospital, Stavanger, Norway
¹³III. Medizinische Klinik, Universitätsmedizin Mannheim, Universität Heidelberg, Mannheim, Germany
¹⁴Department of Clinical Genetics, Skåne University Hospital, Lund, Sweden
¹⁵Dept of Hematology, St Olavs Hospital, Trondheim, Norway
¹⁶Inserm U1035, Université Bordeaux Segalen, Bordeaux, France
¹⁷Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
¹⁸Inserm CIC 1402, University Hospital, Poitiers, France

Timothy P. Hughes, MD, MBBS, FRACP, FRCPA¹, Marco Aurelio Salvino, MD, PhD², Ong Tee Chuan, MD^3*, Alaa Elhaddad, MD, PhD⁴, Kudrat Abdulkadyrov, MD, PhD^5*, Jake Shortt, MD^6*, Hang Quach, MD^7*, Carolina Pavlovsky, MD^8*, Vernon J. Louw, MBChB, M.Med, FCP(SA), PhD(HPE)⁹, Lee-Yung Shih, MD¹⁰, Anna G. Turkina, MD, PhD¹¹, Luis Meillon, MD¹², Yu Jin, MS^13*, Sadhvi Khanna, MS^14*, Darshan Dalal, MD, PhD, MPH^13* and Jeffrey H. Lipton, MD, PhD¹⁵

¹South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia
²Clinical Research- Hospital Sao Rafael, Monte Tabor & Hospital das Clinicas- Universidade Federal da Bahia, Salvador, Brazil
³Hospital Ampang, Selangor, Malaysia
⁴National Cancer Institute, Cairo University, Cairo, Egypt
⁵Russian Research Institute of Hematology and Transfusiology, Saint Petersburg, Russia
⁶Monash Health, Clayton, Australia
⁷University of Melbourne, St. Vincent's Hospital, Victoria, Australia
⁸FUNDALEU, Buenos Aires, Argentina
⁹University of the Free State, Bloemfontein, South Africa
¹⁰Division of Hematology, Chang Gung Memorial Hospital-Linkou, Chang Gung University, Taipei, Taiwan
¹¹Scientific Advisory Department of Chemotherapy of Myeloproliferative Disorders, Federal State Budgetary Institution Hematology Research Center of Healthcare Ministry of Russian Federation, Moscow, Russia
¹²CMN Siglo XXI, Hospital de Especialidades, Mexico City, Mexico
¹³Novartis Pharmaceuticals Corporation, East Hanover, NJ
¹⁴Novartis Healthcare Pvt. Ltd., Hyderabad, India
¹⁵Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada

Gabriel Etienne, MD, PhD^1*, Delphine Rea, MD, PhD^2*, Joelle Guilhot, PhD³, Francois Guilhot, MD⁴, Françoise Huguet, MD^5*, Laurence Legros, MD^2,6*, Franck E. Nicolini, MD, PhD^7,8, Aude Charbonnier^2*, Agnes Guerci, MD^9*, Bruno R. Varet, MD¹⁰, Philippe Rousselot, MD, PhD, Professor^2,11* and Francois Xavier Mahon, MD, PhD¹²

¹institut Bergonié, Bordeaux, France
²Fi-LMC group, Pessac, France
³Inserm CIC 1402, University Hospital, Poitiers, France
⁴Hematology department, Inserm CIC 1402, CHU de Poitiers, Poitiers, France
⁵Hematology department, Institut universitaire du cancer de Toulouse, Toulouse, France
⁶Hematology department, Hopital Archet 1, CHU Nice, Nice, France
⁷Hôpital Haut Lévêque, Fi-LMC group, Pessac, France
⁸Centre Hospitalier Lyon Sud, Pierre-Bénite, France
⁹CHU de Nancy, Nancy, France
¹⁰Hematology Dept., Paris Descartes Univ. Necker Hospital, Paris, France
¹¹University of Versailles St-Quentin-en-Yvelines, Versailles, France
¹²Hematology Laboratory, Bordeaux University,Bordeaux Hospital, INSERM 1035, BORDEAUX, France

Simona Soverini, PhD¹, Caterina De Benedittis, PhD^1*, Fausto Castagnetti, MD/PhD², Gabriele Gugliotta, PhD^1*, Manuela Mancini, PhD^1*, Giorgina Specchia, Pr, MD³, Domenico Russo, MD, PhD⁴, Alessandra Iurlo, MD, PhD^5*, Massimiliano Bonifacio, MD^6*, Marzia Salvucci^7*, Tamara Intermesoli, MD^8*, Paolo Avanzini, MD^9*, Sara Galimberti, MD^10*, Bruno Martino, MD^11*, Elena Maino, MD^12*, Anna Rita Scortechini, MD^13*, Katerina Machova Polakova^14*, Giuseppe Saglio¹⁵, Fabrizio Pane, MD¹⁶, Gianantonio Rosti, MD^1*, Michele Baccarani¹⁷, Michele Cavo, MD^1* and Giovanni Martinelli, MD, PhD²

¹"Seràgnoli" Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
²Bologna University School of Medicine, Bologna, Italy
³Department of Emergency and Organ Transplantation, Section of Hematology with Transplantation, Medical Sch, University of Bari, Bari, Italy
⁴Chair of Hematology, Unit of Blood Diseases and Stem Cell Transplantation, University of Brescia, Brescia, Italy
⁵Division of Hematology, IRCCS Maggiore Policlinico Hospital Foundation, Milano, Italy
⁶Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
⁷S. Maria delle Croci Hospital, Ravenna, Italy
⁸Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
⁹Hematology, S.Maria Nuova Hospital, Reggio Emilia, Italy
¹⁰UO University Hematology, AOU Pisana, Pisa, Italy
¹¹Hamatology Dept., Ospedali Riuniti Bianchi Melacrino Morelli, Reggio Calabria, Italy
¹²Ospedale dell Angelo-Ematologia, Mestre, Italy
¹³Azienda Ospedaliera Universitaria - Ospedali Riuniti di Ancona, Ancona, Italy
¹⁴Institute of Hematology and Blood Transfusion, University of Prague, Prague, Czech Republic
¹⁵University of Turin, Orbassano, Italy
¹⁶Department of Biochemistry and Medical Biotechnologies, Federico II University, Napoli, Italy
¹⁷Institute of Hematology, University of Bologna, Bologna, Italy

Aytug Kizilors, PhD^1,2*, Elena Crisa, MD^3*, Nicholas Lea, PhD^2,4*, Steven Best, PhD^5*, Mian Syed, PhD^6*, Robin M. Ireland, FRCP, FRCPath^7,8, Maadh Aldouri, FRCPath^9*, Christopher Pocock¹⁰, Timothy Corbett, FRCP, FRCPath^11*, Emily Elizabeth Bart-Smith, MRCP, BSc^12*, Richard Gale, FRCPath, FRCP^13*, Clare Wykes, FRCPath, FRCP^14*, Simon Weston-Smith, FRCP, FRCPath^15*, Donal McLornan, MD PhD^16*, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA^12,17, Ghulam J. Mufti, MD, PhD^6,18 and Hugues de Lavallade, MD, PhD^2,19*

¹Haematology, Laboratory for Molecular Haemato-Oncology, King's College Hospital NHS Foundation Trust/King's College London, London, United Kingdom
²Haematology, King's College London, London, United Kingdom
³Haematology, King's College Hospital NHS Foundation Trust/King's College London, London, United Kingdom
⁴Laboratory for Molecular Haemato-Oncology, King's College Hospital NHS Foundation Trust/King's College London, London, United Kingdom
⁵Laboratory for Molecular Haemato-Oncology, Haematology, King's College Hospital NHS Foundation Trust, London, United Kingdom
⁶Haematological Medicine, King's College London, London, United Kingdom
⁷Haematological Medicine, King's College Hospital NHS Foundation Trust, London, England
⁸Department Of Haematological Medicine, King's College Hospital, London, United Kingdom
⁹Haematology, Medway Maritime Hospital, Gillingham, United Kingdom
¹⁰East Kent Hospitals, Canterbury, United Kingdom
¹¹Haematology, Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom
¹²Haematology, King's College Hospital NHS Foundation Trust, London, United Kingdom
¹³Haematology, MAIDSTONE AND TUNBRIDGE WELLS NHS TRUST, Tunbridge Wells, United Kingdom
¹⁴Haematology, MAIDSTONE AND TUNBRIDGE WELLS NHS TRUST, Maidstone, United Kingdom
¹⁵Haematology, EAST SUSSEX HEALTHCARE NHS TRUST, St Leonards-on-Sea, United Kingdom
¹⁶Department of Haematological Medicine, King’s College Hospital NHS Foundation Trust, London, United Kingdom
¹⁷haematology, King's College London, London, United Kingdom
¹⁸Department of Haematological Medicine, King's College Hospital, NHS Foundation Trust, London, United Kingdom
¹⁹Haematological Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom

Laura N Eadie, PhD^1,2*, Timothy P. Hughes, MD, MBBS, FRACP, FRCPA^2,3,4 and Deborah L White, PhD, FFSc (RCPA)^1,2

¹Cancer Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, Australia
²School of Medicine, University of Adelaide, Adelaide, Australia
³Department of Haematology, SA Pathology, Adelaide, Australia
⁴South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia